Beyond the budget impact model: A case study for glucarpidase and the real cost of managing curable toxicities.
Saved in:
| Title: | Beyond the budget impact model: A case study for glucarpidase and the real cost of managing curable toxicities. |
|---|---|
| Authors: | Williams SA; Star Biopharma Consulting, LLC, Malvern, PA, USA., Weiss RJ; Star Biopharma Consulting, LLC, Malvern, PA, USA. |
| Source: | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2025 Dec; Vol. 31 (8), pp. 1363-1366. Date of Electronic Publication: 2025 Sep 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-092X |
|---|---|
| DOI: | 10.1177/10781552251374598 |
